Hatziioanou et al., 2013 - Google Patents
A representative of the dominant human colonic Firmicutes, Roseburia faecis M72/1, forms a novel bacteriocin-like substanceHatziioanou et al., 2013
- Document ID
- 14170066537088030607
- Author
- Hatziioanou D
- Mayer M
- Duncan S
- Flint H
- Narbad A
- Publication year
- Publication venue
- Anaerobe
External Links
Snippet
During screening of human gut isolates in search of novel antimicrobials, the butyrate- producing strain Roseburia faecis M72/1 was found to produce an inhibitory substance active against Bacillus subtilis. Partial purification of the antimicrobial was achieved and …
- 241000761526 Roseburia faecis M72/1 0 title abstract description 18
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
- C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hatziioanou et al. | A representative of the dominant human colonic Firmicutes, Roseburia faecis M72/1, forms a novel bacteriocin-like substance | |
| Zhao et al. | Purification and characterization of plantaricin JLA-9: a novel bacteriocin against Bacillus spp. produced by Lactobacillus plantarum JLA-9 from Suan-Tsai, a traditional Chinese fermented cabbage | |
| Xie et al. | Isolation and characterization of a bacteriocin produced by an isolated Bacillus subtilis LFB112 that exhibits antimicrobial activity against domestic animal pathogens | |
| Mareková et al. | Isolation and characterization of a new bacteriocin, termed enterocin M, produced by environmental isolate Enterococcus faecium AL41 | |
| Pascual et al. | Purification and Partial Characterization of Novel Bacteriocin L23 Produced by Lactobacillus fermentum L 23 | |
| Pasquale et al. | Occurrence of toxigenic Clostridium difficile in edible bivalve molluscs | |
| Shin et al. | Isolation and characterization of bacteriocin‐producing bacteria from the gastrointestinal tract of broiler chickens for probiotic use | |
| Sabo et al. | Bioprospecting of probiotics with antimicrobial activities against Salmonella Heidelberg and that produce B-complex vitamins as potential supplements in poultry nutrition | |
| Caly et al. | The safe enterocin DD14 is a leaderless two-peptide bacteriocin with anti-Clostridium perfringens activity | |
| Nascimento et al. | Probiotic potential and safety of enterococci strains | |
| Ben Braïek et al. | Isolation and characterisation of an enterocin P-producing Enterococcus lactis strain from a fresh shrimp (Penaeus vannamei) | |
| Yadav et al. | Molecular characterization and antimicrobial resistance profile of Clostridium perfringens type A isolates from humans, animals, fish and their environment | |
| Sequeiros et al. | Potential aquaculture probiont Lactococcus lactis TW34 produces nisin Z and inhibits the fish pathogen Lactococcus garvieae | |
| Baumgartner et al. | Antimicrobial resistance of Yersinia enterocolitica strains from human patients, pigs and retail pork in Switzerland | |
| Carasi et al. | Safety and potential beneficial properties of Enterococcus strains isolated from kefir | |
| Xia et al. | Probiotic potential of Weissella strains isolated from horse feces | |
| Zhao et al. | Purification and characterization of bacteriocin produced by Lactobacillus rhamnosus zrx01 | |
| Khalil et al. | Probiotic characteristics of exopolysaccharides-producing lactobacillus isolated from some traditional Malaysian fermented foods | |
| Zhijing et al. | Screening beneficial bacteriostatic lactic acid bacteria in the intestine and studies of bacteriostatic substances | |
| Fugaban et al. | Probiotic potential and safety assessment of bacteriocinogenic Enterococcus faecium strains with antibacterial activity against Listeria and vancomycin-resistant enterococci | |
| Mangrolia et al. | Staphylococcus xylosus VITURAJ10: Pyrrolo [1, 2α] pyrazine-1, 4-dione, hexahydro-3-(2-methylpropyl)(PPDHMP) producing, potential probiotic strain with antibacterial and anticancer activity | |
| Perumal et al. | Antimicrobial, cytotoxic effect and purification of bacteriocin from vancomycin susceptible Enterococcus faecalis and its safety evaluation for probiotization | |
| Zommiti et al. | Purification and characterization of a novel anti-campylobacter bacteriocin produced by Lactobacillus curvatus DN317 | |
| Jozefiak et al. | Dietary divercin modifies gastrointestinal microbiota and improves growth performance in broiler chickens | |
| Hwanhlem et al. | Bacteriocin-producing lactic acid bacteria isolated from mangrove forests in Southern Thailand as potential bio-control agents: purification and characterization of bacteriocin produced by Lactococcus lactis subsp. lactis KT2W2L |